Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 26, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001770295-26-000003
Filed / recorded
Feb 26, 2026, 9:36 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
METLIFE INC
Issuer CIK
1099219
Ticker
MET
Reporting person
Marlene Debel
Relationship
Officer
Officer title
EVP & Chief Risk Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 24, 2026
Transaction code
A
Shares / units
14,870
Acquired / disposed
Acquired (A)
Shares owned after
164,137
Ownership form
Direct
Amendment
No
Footnotes from the filing
Shares acquired from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
